English | Español
Patient Daily | Feb 6, 2026

AbbVie emphasizes potential of new psychedelic therapy as market interest grows
Patient Daily | Feb 6, 2026

La Trobe researchers develop highly sensitive test strip for disease detection
Patient Daily | Feb 6, 2026

New therapy may offer monthly alternative to daily pills after kidney transplantation
Patient Daily | Feb 6, 2026

Duplicate medical records linked to increased risk of death in US hospitals
Patient Daily | Feb 6, 2026

Lack of pediatric data limits access to key antibiotics for severe childhood infections
Patient Daily | Feb 6, 2026

Study links shorter working hours with improved employee wellbeing and productivity
Patient Daily | Feb 6, 2026

UC Irvine study links brain estrogen levels to women’s risk of PTSD and dementia
Patient Daily | Feb 6, 2026

Study finds air ambulance care linked to improved trauma survival rates

Trending
+ Pharmaceuticals
Patient Daily | Feb 3, 2026

Drug Channels President on 340B: 'no one knows where the 340B profits go, or which patients benefit'
+ Pharmaceuticals
Patient Daily | Feb 2, 2026

Clinical trial landscape shifts globally as China increases role in innovation
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

FDA lifts hold on Intellia's phase III ATTR gene editing trial
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Summit Therapeutics’ ivonescimab faces key FDA decision as potential Keytruda competitor